Prime vendor pharm branch-philadelphia
Ended Indefinite Delivery Contract Awarded
- Contract number
- SPE2DB22D9251
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 142 $1,048,204 obligated
Award facts
- Opportunity
-
- SPM2DP13R0007 Solicitation number
- Combined order value
- $1,048,204 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling <1% used
- $499,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency awarded an indefinite-delivery/indefinite-quantity contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products and medical supplies in support of DLA and Department of Defense operations. Over the period of performance from April 2022 through December 2025, DMS Pharmaceutical Group Inc. serves as the prime contractor fulfilling delivery orders against the contract for items including botulinum toxin, contraceptive implants, vaccines, intrauterine devices, and other medical commodities. Task orders issued by DLA to DMS Pharmaceutical Group Inc. under the contract have included firm fixed price delivery orders ranging from approximately $10 to over $90,000 to supply pharmaceuticals and medical supplies from DMS Pharmaceutical Group Inc.'s facility in Park Ridge, Illinois for use in DLA's medical logistics programs. No set aside designations were applied to orders issued pursuant to this IDV contract aimed at supporting the procurement of critical pharmaceutical and medical supplies for Department of Defense medical treatment facilities and personnel worldwide.
The indefinite-delivery/indefinite-quantity contract awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc. establishes the prime vendor arrangement whereby DLA fulfills its mandate to provide logistical support for Department of Defense medical readiness programs through the issuance of delivery orders against the contract over its three year period of performance. Task orders issued under the contract range in value and period of performance and supply various pharmaceutical products and medical supplies from DMS Pharmaceutical Group Inc.'s Illinois facility to support DLA's global supply chain responsibilities in equipping military treatment networks.
Task orders
Show 40 more
Latest 50 of 142 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DB22D9251?
SPE2DB22D9251 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 28, 2022.
How much is contract SPE2DB22D9251 worth?
Orders under SPE2DB22D9251 have obligated $1,048,204. SPE2DB22D9251's own ceiling is $499,999,999.
How many orders have been placed under contract SPE2DB22D9251?
142 orders have been placed under SPE2DB22D9251, the latest on October 28, 2025.
Who can order from contract SPE2DB22D9251?
SPE2DB22D9251 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DB22D9251 competed?
The extent of competition for SPE2DB22D9251 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV